Pharmaceuticals Research This is an OPML file. It can be used to export all the MedWorm RSS feeds on this topic into your personal RSS reader (usually you have to save this file to your own computer before clicking on an Import OPML command in your own feed reader to upload the file which will then import all the feeds) or it can be used by webmasters to integrate MedWorm feeds with their own website. This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Find the best Christmas presents and January Sales in the UK with this simple shopping directory.

• Default
• News
• Research
• Blogs
• Podcasts
• Events
• Funding
• Alerts
• Clinical Trials
• Forums
• Top 20

CareSouth expands services in Florida
CareSouth Health System Inc. has expanded its services in the state by purchasing Alliance Care, a provider of home health care, private duty and physician house call services. In a statement, the company said the transaction was one of the largest in the company's history and concluded on Aug. 8. Alliance Care will operate as CareSouth Homecare Professionals in several places in Florida including Sarasota, Bradenton and Tampa. Most Alliance Care employees will keep their jobs with the new company…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 10, 2012 Category: Pharmaceuticals Source Type: research

Children’s Services Council of Palm Beach County cuts budget by $4M
The Children’s Services Council of Palm Beach County looks to slash its budget by $4 million next year and plans to cut funding to eight programs. The Palm Beach Post reported that the council’s budget would decline to $110 million from $114 million this year. The Children’s Services Council is an independent special district established by county voters, who dedicated a source of funding for children and family services. One of the programs losing funding by Sept. 30 is the School and Family…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 10, 2012 Category: Pharmaceuticals Source Type: research

USF cardiologist joins Okyanos Heart Institute council
Dr. Leslie Miller, chair of the University of South Florida’s Department of Cardiovascular Medicine, has joined Okyanos Heart Institute’s advisory council. Miller will provide the institute, based in Freeport, Bahamas, with insight on heart function and cardiac cell therapy, a written statement said. The institute’s advisory council promotes the highest standard of care for patients with chronic coronary artery disease.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 10, 2012 Category: Pharmaceuticals Source Type: research

Parent company of Orange Park, Memorial hospitals under scrutiny
Spokesmen at Northeast Florida’s HCA-owned hospitals have declined comment on a New York Times story that some of the hospitals in the chain were performing unnecessary cardiac procedures. Memorial Hospital in Arlington and Orange Park Medical Center are owned by Nashville-based HCA (NYSE: HCA). Florida Gov. Rick Scott is the founder and former CEO of HCA. HCA has posted a statement regarding the Times story on its website. After a registered nurse at Lawnwood Regional Medical Center complained…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 10, 2012 Category: Pharmaceuticals Authors: Ashley Gurbal Kritzer Source Type: research

Minority Business Leaders: Nadeem Bezar
Kolsby Gordon Robin Shore & Bezar Born and raised in New York’s Westchester County to Indian immigrant parents, Nadeem Bezar first came to Philadelphia to attend Temple University’s Beasley School of Law in 1988. And he never left. After graduating three years later, he spent one year working at White & Williams before joining Kolsby Gordon Robin Shore & Bezar, one of the city’s better-known plaintiff personal injury law firms. The firm was founded by Herbert Kolsby in 1953 and then piloted…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 10, 2012 Category: Pharmaceuticals Authors: Jeff Blumenthal Source Type: research

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
Conclusions/interpretation  Meta-analysis of currently available RCT data does not support the hypothesis that metformin lowers cancer risk by one-third. Eligible trials also showed no significant effect of metformin on all-cause mortality. However, limitations include heterogeneous comparator types, absent cancer data from two trials, and short follow-up, especially for mortality. Content Type Journal ArticleCategory ArticlePages 1-11DOI 10.1007/s00125-012-2653-7Authors R. J. Stevens, Department of Primary Care Health Sciences, University of Oxford, Woodstock Road, Oxford, OX2 6GG UKR. Ali, Cancer E...
Source: Diabetologia - August 9, 2012 Category: Endocrinology Tags: Diabetologia Source Type: research

Maryland health exchange policies shaping up
Temporary policies for the Maryland Health Benefit Exchange will be submitted to the state Senate finance committee Aug. 16, exchange leaders said Thursday. The exchange needs to establish preliminary policies so companies and organizations affected by the exchange can begin work preparing for changes. Federal deadlines for launching state exchanges, which must be in place by 2014, add immediacy for establishing guidelines, even temporary ones, said Rebecca Pearce, the exchange’s executive director. The…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Sarah Gantz Source Type: research

KV: Judge approved continued operations during bankruptcy
KV Pharmaceutical Co. officials said that a bankruptcy court has approved its “first day” motions on either an interim or final basis, which will allow it to cover obligations to employees and warehouse and common carrier providers, and continue to use its current cash management system. “Approval of these first day motions helps provide the flexibility we need to complete this process quickly and efficiently,” KV Pharmaceutical President and CEO Greg Divis said in a statement. The U.S.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Greta Weiderman Source Type: research

Talon Therapeutics wins approval for leukemia drug
The generally accepted notion in the drug-development space is that it takes $1 billion or more and 10-plus years to bring a therapeutic to market. Then there's Talon Therapeutics Inc. The San Mateo company (OTCBB: TLON) won accelerated approval Thursday from the Food and Drug Administration regarding its cancer-fighting drug Marqibo. The company's accumulated deficit from its founding in December 2002 to the end of the first quarter? $210.4 million. Not that it has been easy for Talon. Over the…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

Lowell General's cash swells as patient mix changes
Fueled by a strong uptick in outpatient and oncology-related business, Lowell General Hospital saw its cash position surge amid double-digit spikes in revenue and operating profit in the first nine months of its current fiscal year. The hospital’s strong financial performance came despite a continued rise in Medicare and Medicaid patient care, which together comprise 56 percent of Lowell General’s total revenue versus 49 percent in 2006, according to financial filings. The government-funded…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Craig Douglas Source Type: research

EMerge Health growing, moves to larger space
EMerge Health Solutions is moving to larger space along Interstate 71 in Mason to accommodate its growth. The startup firm made its headquarters in the Mason Municipal building in February, taking about 900 square feet of space. It relocated to a 2,500-square-foot space at 7264 Columbia Road. The company developed software that allows doctors to document endoscopic procedures as they go using voice commands. It currently employs five and expects to have 20 employees by the end of the year. Emerge…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Source Type: research

CenterPoint cutting contracts
CenterPoint Human Services, the Local Management Entity that oversees mental health services in Forsyth, Stokes, Davie and Rockingham counties, will reduce contracts to providers by an average of 8 percent in fiscal 2013, the agency said. Those cutbacks are the result of reduced state funding in the amount of $1 million, which came on top of $772,553 in reduced federal block grants for substance abuse treatments. The Winston-Salem-based agency was informed of the state cuts in July. CenterPoint…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Matt Evans Source Type: research

DBJ honors Healthiest Employers in Dayton at event
About 150 of Dayton’s most fit gathered Wednesday morning at the Dayton Business Journal’s second annual Healthiest Employers event. Hosted at the Crowne Plaza, the event recognized the top 13 employers in the region for their innovative and successful employee health programs. Dan Parker spoke on behalf of his company, Delta Dental, the title sponsor for the event. “The mouth is a leading indicator of your overall health, so we think it makes sense to insure the mouth,” he said. Anthem…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Olivia Barrow Source Type: research

Gillibrand bill would set aside $200M for biotech commercialization
Sen. Kirsten Gillibrand is introducing a bill to create a $200 million fund to help biotech companies move discoveries out of the lab and into the marketplace. Gillibrand (D-NY) announced the legislation, called the America Innovates Act, today at the University at Albany’s East Campus. Under the bill, research institutions would be able to tap into what would be called the American Innovation Bank for money to commercialize scientific discoveries. Gillibrand said Congress has already set aside…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Richard A. D'Errico Source Type: research

Growing Nodality strikes drug-development deal with Pfizer
Nodality Inc. scored a deal Thursday to help Pfizer Inc., the world's largest drug maker, better develop drugs. The multi-year deal, financial terms for which weren't disclosed, initially will focus on autoimmune diseases, particularly lupus. Plus, Pfizer has an option to use Nodality's technology to develop companion diagnostics. Pfizer Venture Investments, the drug maker's venture capital arm, already had invested in Nodality four years ago. Using technology licensed out of Garry Nolan's Stanford…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: Ron Leuty Source Type: research

Baptist Hospital, Trilogy on best employers list
Baptist Hospital East and Trilogy Health Services both made Modern Healthcare magazine’s list of best places to work in health care. The recognition program, now in its fifth year, honors workplaces in health care that enable employees to perform at their optimum level to provide patients and customers with the best possible care, products and services, according to the magazine. One hundred health care organizations from across the country are on the list, which was revealed in alphabetical…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2012 Category: Pharmaceuticals Authors: David A. Mann Source Type: research

Obama hammers Romney on women’s issues at Denver rally
President Barack Obama, campaigning in Denver Wednesday, said opponent Mitt Romney’s views on women’s health issues are “more suited to the 1950s than the 21st century.” Appearing at the downtown Auraria Campus’ event center to open a two-day campaign swing through Colorado, Obama spoke to a mostly-female crowd of about 4,000 behind a sign touting “Women’s Health Security.” “The decisions that affect a woman’s health — they’re not up to politicians; they’re not up to insurance…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Mark Harden Source Type: research

Salix strikes licensing deal with Alfa Wassermann
Raleigh’s largest home-grown pharmaceutical manufacturer has hashed out a deal with Alfa Wassermann S.p.A. for an extended release formulation of its lead drug. With the deal, Salix (Nasdaq: SLXP) will pay Alfa Wassermann, based in West Caldwell, N.J, $10 million up front, and an additional $25 million if the new formulation is approved by the U.S. Food and Drug Administration to treat Crohn’s disease. Alfa Wassermann also is eligible to receive other sales-based milestones and royalties. In…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Jason deBruyn Source Type: research

Seattle Genetics loss down, revenue up in Q2; stock dips
Seattle Genetics decreased its losses in the second quarter compared to a year ago, but rising revenues still missed analyst expectations, sending the company's stock down. The Bothell-based biotech (NASDAQ: SGEN) reported a net loss of $17.2 million, or 15 cents per share, compared to $51.5 million, or 45 cents per share, for the second quarter of 2011. Revenues nearly quadrupled, coming in at $48.8 million compared to $13.1 million a year ago. But the number still fell short of analysts' expectations…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Jennifer Sokolowsky Source Type: research

Earnings: Advocat posts $433k loss
Brentwood-based Advocat (Nasdaq: AVCA) posted a $433,000 loss in the first quarter of 2012, down from a $3 million profit during the same period last year. The loss of 9 cents per share came on revenue of $77 million. "Although we continued to make progress against our long-term strategic plan in the first quarter, the combination of reductions in Medicare reimbursement effected by CMS, a $0.6 million year-over-year increase in professional liability expense, and the cost increases in facility…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Annie Johnson Source Type: research

Piedmont Healthcare names interim CEO
Dr. Patrick Battey has been named interim CEO of Piedmont Healthcare. The vascular surgeon succeeds former President and CEO R. Timothy Stack who died July 30 from an undisclosed illness. Piedmont spokesman Matt Gove declined to comment on whether Piedmont Healthcare would conduct an extenal search for the CEO job. Battey, who is chair of Piedmont Healthcare’s board of directors, has served in several leadership roles, including chair of Piedmont Hospital’s board of directors and president…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Urvaksh Karkaria Source Type: research

July marks a slow month for CEO turnover
July departures of CEOs are the lowest they have been this year, falling 16.2 percent since June, according to new data from Challenger, Gray & Christmas Inc. The outplacement consultancy's monthly report suggests July's exits were at 83 compared to 104 turnovers in the same period of 2011. CEO departures have not been that low since December, when 83 changes were also recorded. The company has tracked a total of 682 CEO turnovers so far thus year, or 2.5 percent lower the same time last year.…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Source Type: research

Children’s Hospital Colorado buys more land
Children’s Hospital Colorado is ready to expand. There aren’t any specific plans yet, but the Aurora hospital recently purchased a 12.6-acre plot of land at 12900 E. Colfax Ave., Aurora, for $10.42 million from Capri Aurora LLC. The site has abandoned mobile homes on it; it used to be the Capri Village Mobile Home Park. It’s adjacent to its newly opened Clinics at Fitzsimons Village location and across the street from the main campus hospital. A hospital spokeswoman said the land would be…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Dennis Huspeni Source Type: research

Scottsdale Healthcare to share in $200M for nurse training
In an effort to address the primary care provider shortage across the state, Scottsdale Healthcare has been selected among five hospitals nationwide for a $200 million federally funded project. The U.S. Department of Health and Human Services gave a four-year, $200 million grant to five U.S. hospitals, including Scottsdale Healthcare to train advanced practice registered nurses, or APRNs. In Arizona, SHC will team with Arizona State University, University of Arizona, Northern Arizona University…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: research

Today: SoMad and tech hubs
Some things you may have missed on the Web today: • Social Madness, a contest by the Philadelphia Business Journal and our sister papers to measure and reward social engagement, is heading into the final rounds. Only one Philadelphia-area company is still in the running – Medical ID Marketplace, a Hope Paige Company. Find out who they are and what they do in a blog by PBJ Reporter John George. • So where are the tech hubs around the world? Find out with the Upstart Business Journal’s slideshow…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Craig Ey Source Type: research

A study on novel artificial lung surfactants incorporated with partially fluorinated amphiphiles.
Abstract Lung surfactants (LS), a complex of ∼90 wt% lipids (mainly dipalmitoylphosphatidylcholine or DPPC) and ∼10 wt% surfactant proteins (SP-A, -B, -C, and -D), adsorb to an air-alveolar fluid interface and then lower its surface tension down to near zero during expiration. Intratracheal instillation of exogenous LS preparations can effectively compensate for surfactant deficiency in premature infants with respiratory distress syndrome (RDS). Surfacten^® (Mitsubishi Tanabe Pharma Corporation, Osaka, Japan), a modified bovine lung extract and an effective surfactant replacement in treat...
Source: Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan - August 8, 2012 Category: Drugs & Pharmacology Authors: Nakahara H Tags: Yakugaku Zasshi Source Type: research

Boomers more worried about retirement security than jobs
Enough talk about jobs. For one crucial voting bloc -- Americans age 50 and over -- retirement security is a much bigger issue in this year’s election. Nonretired baby boomers are more anxious about the economy than either retirees or Americans in the 18-49 age bracket, according to a new survey conducted for AARP by Hart Research Associates and GS Strategy Group. The biggest financial worry for the 50-plus set isn’t keeping or finding a job -- that’s No. 9 on the list. Instead, they’re…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2012 Category: Pharmaceuticals Authors: Kent Hoover Source Type: research

Swedish firm Capish sets up shop at Port Business Incubator
The University City Science Center Port Business Incubator has landed its first company with Swedish roots. Capish Inc., the U.S. subsidiary of Capish International, has taken office space in the Bullpen — a co-working space in the incubator at 3711 Market Street in Philadelphia. The company is developing software that manages, evaluates and visualizes preclinical and clinical data collected in the drug development process for both big pharma and small biotech companies. “Capish is planning…
Source: bizjournals.com Health Care:Physician Practices headlines - August 8, 2012 Category: American Health Authors: John George Source Type: research

Evaluation of dopamine D2/D3 and serotonin 5-HT2A receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography
Conclusions  Compared with olanzapine, lurasidone preferentially binds to D2/D3 receptors rather than 5-HT2A receptors in common marmosets. These results suggest that the contribution of in vivo 5-HT2A receptor blocking activity to the pharmacological profile of lurasidone might differ from olanzapine in terms of the low risk of extrapyramidal syndrome and efficacy against negative symptoms. Content Type Journal ArticleCategory Original InvestigationPages 1-11DOI 10.1007/s00213-012-2815-9Authors Shunsuke Nakazawa, RIKEN Center for Molecular Imaging Science, 6-7-3 Minatojima-Minamimachi, Chuo-ku, Kobe,...
Source: Psychopharmacology - August 8, 2012 Category: Psychiatry Tags: Psychopharmacology Source Type: research

HCA is subject of federal probes
HCA Holdings Inc. is the focal point of two federal probes related to billing practices for heart procedures, company officials have disclosed. The Nashville Business Journal reported that the hospital owner, which owns Louisville-based National Patient Account Services, also put out word about a story The New York Times was working on about physician decisions and patient volume related to cardiac catheterizations and certain coronary interventions. The Times story, published Tuesday, said an…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 7, 2012 Category: Pharmaceuticals Source Type: research

Kaleida signs new ER contract for Millard Suburban
A new team of physicians will begin staffing the Millard Fillmore Suburban Hospital emergency room, effective Sept. 1. Kaleida Health, parent of Millard Suburban, has signed a contract with FDR Medical Services of Orchard Park, expanding a relationship with DeGraff Memorial Hospital that began in 2008. The company also provides emergency department coverage at Brooks Memorial Hospital in Dunkirk, United Memorial Medical Center in Batavia, Niagara Falls Memorial Medical Center, and the ExcelCare…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 7, 2012 Category: Pharmaceuticals Authors: Tracey Drury Source Type: research

NC Research Campus adds post-doctoral fellowship
Two operations at the N.C. Research Campus have created a post-doctoral fellowship that’s the first of its kind at the biotech hub in Kannapolis. It’s a joint initiative of the N.C. State University Plants for Human Health Institute and the Dole Nutrition Research Laboratory.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 7, 2012 Category: Pharmaceuticals Source Type: research

Prince George's County considers pitches for state health funding
Prince George's County is considering pitching the state of Maryland for millions of dollars for a healthly neighborhood program, The Gazette reported. The Health Enterprise Zones were authorized earlier this year by the General Assembly. Under the plan, the state will provide $4 million to support multiple zones. Program proposals are due by the end of September, and the winners will be selected in December. The zones will fund a new health-focused initiative within a community tasked with finding…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 7, 2012 Category: Pharmaceuticals Source Type: research

Health care costs to increase 7% for large employers
Large employers expect their health insurance costs to increase 7 percent next year, according to a survey conducted by the National Business Group on Health, Bizjournals' Washington Bureau reports. “Rising health care costs continue to plague employers at an alarming rate,” said Helen Darling, the association’s president and CEO. “Although cost increases have stabilized somewhat, they are still on a higher base from last year and are simply not sustainable, especially when our nation’s…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 7, 2012 Category: Pharmaceuticals Source Type: research

AZ Attorney General to seek court ruling making medical marijuana dispensaries illegal
Just as the big drawing to determine who will be selected to operate medical marijuana dispensaries throughout the state, Arizona Attorney General Tom Horne has issued an opinion that may put the dispensaries in limbo again.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 7, 2012 Category: Pharmaceuticals Source Type: research

What you missed: Kansas City may use TIF money for soccer fields
Kansas City is considering what could be a $20 million project to revamp Sporting Kansas City's training facility in Swope Park and surround it with more soccer fields and amenities to draw youth tournaments. To pay for it, officials have suggested expanding the boundaries of an existing tax increment financing plan that has a balance left in its special allocation fund. But the potential for that $11 million to go toward the project has raised questions among taxing jurisdictions. (Read the full…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Suzanna Stagemeyer Source Type: research

HCA posts 2Q earnings gain
HCA Holdings Inc. reported net income of $391 million, or 85 cents a share, for the second quarter of 2012, compared to net income of $229 million, or 43 cents a share, for the second quarter of 2011. Revenue for the just-ended quarter increased 11.9 percent to $8.1 billion, compared to $7.2 billion a year ago, a statement said. Revenue growth in the second quarter of 2012 was driven by increased patient volume and the consolidation of HCA’s HealthONE venture, the statement said. HCA (NYSE:…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Tampa Bay Business Journal Source Type: research

Cincinnati medical startups land $40M in capital
Health care startup companies in Ohio attracted the biggest investments in the Midwest during the first half of the year, according to a new report. A total of 44 startups in Ohio attracted $126.4 million combined from investors in the first six months of 2012, according to the BioEnterprise Midwest Health Care Venture Investment Report. The Ohio startups accounted for about a quarter of the $510.6 million of investments made in 97 health care companies across the Midwest, which covers all or parts…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Source Type: research

Southern Indiana company earns NASA contract
Techshot Inc., based at the Purdue Research Park of Southeast Indiana, has been awarded a NASA contract worth about $750,000. The contract calls for the company to develop a prototype of the multi-specimen variable-gravity platform, which is a device designed and developed to study how gravity affects living things, according to a news release. John Vellinger, chief operating officer of Techshot, said in the news release that studying the effects of gravity on living things provides new insights…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Andrew Robinson Source Type: research

Ron Whiting resigns from health care coalition to take job in California
Ron Whiting helped launch the Wichita Business Coalition on Health Care in 2008 as a way to engage employers and medical providers on key issues. Now, he’s leaving Wichita. The coalition announced Monday that Whiting had submitted his resignation, effective Sept. 4, to take a position with a national health care organization in Oakland, Calif., where he will serve as director of care delivery, partnerships and relationships. Whiting will leave behind a 53-member organization that includes some…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Josh Heck Source Type: research

ED GOLDMAN: Women helping women
Elaine Whitefeather, director of the Domestic Violence Intervention Center in Citrus Heights, recently celebrated her 60th birthday — and “celebrated” isn’t too strong a word, to hear her tell it. “Sixty is my signature age,” she says. “I’ve been waiting for it since I was a little girl. It meant I would become a ‘gray hair.’ The idea is that by then I’d have learned from my experiences, not just survived them. If you don’t think of life that way, then all you’ve done is…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Ed Goldman Source Type: research

Florida regulators dispute auto insurance savings
A new law designed to cut down on insurance fraud may not save as much as promised, according to Florida regulators. That cautionary statement comes in response to a preliminary report issued last Friday by the state Office of Insurance Regulation. The report said the new law will cut no-fault insurance premiums by 12 to 20 percent, but the Claims Journal reports that figure may be “overly optimistic.” The Journal listed three reasons why the new law may not save as much as anticipated. First,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Source Type: research

‘Urgency Room’ teams up with Allina for third location
Emergency Physicians Professional Association (EPPA) will open an emergency clinic in Vadnais Heights next year, its third such facility in the Twin Cities metro area. The clinics, which are branded as "The Urgency Room," serve as alternatives to hospital emergency rooms and treat patients suffering from conditions such as chest pain and asthma attacks. The new 14,000-square-foot facility, which The Davis Group is developing, will be built adjacent to an Aspen Medical Clinic owned by Allina Health. This…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Katharine Grayson Source Type: research

Wesley Medical Center parent HCA posts Q2 revenue gains
Increased patient volumes and the consolidation of one of its health care entities helped HCA Holdings Inc. post strong revenue numbers in the second quarter of 2012. The Nashville, Tenn.-based company, which is the parent of Wesley Medical Center and Galichia Heart Hospital in Wichita, announced Monday an 11.9 percent increase in revenue over a year ago. HCA’s second-quarter revenue increased to $8.112 billion, from $7.249 billion in the second quarter of 2011. HCA (NYSE: HCA) says the growth…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Josh Heck Source Type: research

Exec VP Ward out at BDSI
Raleigh drug developer BioDelivery Sciences International has terminated the contract of a top executive without cause. The executive, Benny Ward, is a CPA and worked as executive vice president of business and strategic development since September 2010. He will receive a lump sum of $195,000, equal to one year’s salary. In 2011, his total compensation was $236,888. BioDelivery (Nasdaq: BDSI) announced the decision in a regulatory filing late Friday afternoon. The company says it plans to fill…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2012 Category: Pharmaceuticals Authors: Jason deBruyn Source Type: research

Challenging Generic Drug Deals
Pharma companies in Europe, U.S. face scrutiny over so-called pay-to-delay tactics.
Source: Chemical and Engineering News - August 6, 2012 Category: Chemistry Authors: Rick Mullin Source Type: research

In vitro studies on the mechanism of action of VEGF and its inhibitors on blood‐retina barrier
Conclusion VEGF is mainly responsible for disrupting the barrier function of REC. This supports VEGF targeting as a therapeutic concept. Independent research grant by Novartis Pharma, Germany
Source: Acta Ophthalmologica - August 6, 2012 Category: Opthalmology Authors: H DEISSLER, G LANG Tags: 4411 Source Type: research

Preclinical Evaluation of a Novel c-Met Inhibitor in a Gastric Cancer Xenograft Model Using Small Animal PET
Conclusion  These preclinical findings suggest that clinical PET imaging is a useful tool for early response monitoring in clinical studies. Content Type Journal ArticleCategory Research ArticlePages 1-9DOI 10.1007/s11307-012-0580-0Authors Stefan Wiehr, Department of Preclinical Imaging and Radiopharmacy, Laboratory for Preclinical Imaging and Imaging Technology of the Werner Siemens-Foundation, Eberhard Karls University Tübingen, Tübingen, GermanyOliver von Ahsen, Bayer Pharma AG, Berlin, GermanyLars Röse, Bayer Pharma AG, Berlin, GermanyAndre Mueller, Bayer Pharma AG, Berlin, GermanyJulia G. Mannhei...
Source: Molecular Imaging and Biology - August 3, 2012 Category: Molecular Biology Tags: Molecular Imaging and Biology Source Type: research

MRIGlobal gets $3.8M contract to study cancer drugs
The National Cancer Institute has awarded MRIGlobal a five-year, $3.8 million contract to analyze potential drugs in the fight against cancer. Kansas City-based MRIGlobal announced the award Friday, saying this is the 12th consecutive contract from the NCI for the Anti-Cancer Chemicals and Pharmaceutical Formulations Analysis Program. The program deals with bulk pharmaceutical substances and drugs, typically before they’re approved by the U.S. Food and Drug Administration. During the past 43…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: David Twiddy Source Type: research

GlaxoSmithKline completes Human Genome Sciences takeover
GlaxoSmithKline PLC has completed its $3.6 billion takeover of Rockville-based Human Genome Sciences Inc., the final step in a months-long struggle for control of the company. All outstanding shares of Human Genome were acquired for $14.25 per share in cash. Human Genome Sciences agreed last month to be acquired after earlier rejecting an acquisition offer of $13 per share as too low. Glaxo has said the acquisition will add to earnings starting in 2013 and will result in $200 million in cost savings…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 3, 2012 Category: Pharmaceuticals Authors: Jeff Clabaugh Source Type: research